Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Bites and Stings × Cytochrome P-450 Enzyme System × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Bites and Stings 1

Interventions

pembrolizumab 3 blinatumomab 2 enzalutamide 1 durvalumab 1 dostarlimab 1 cemiplimab 1 atezolizumab 1 abiraterone 1 N,N-dicyclohexyl-isoborneol-10-sulfonamide 1 Immune Checkpoint Inhibitors 1 Hydroxyurea 1 Etoposide 1 Etanercept 1 Cytochrome P-450 Enzyme System 1 Carboplatin 1 AMG 757 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03792841 2025-10-16

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Amgen

Phase 1 Terminated

Bites and Stings, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡